Compounds and methods for treatment and diagnosis of chlamydial infection

Details for Australian Patent Application No. 2001280702 (hide)

Owner Corixa Corporation

Inventors Skeiky, Yasir A.W.; Probst, Peter; Skeiky, Yasir A. W.; Bhatia, Ajay; Fling, Steven P.; Fling, Steven P.; Bhatia, Ajay; Probst, Peter

Agent Davies Collison Cave

Pub. Number AU-B-2001280702

PCT Pub. Number WO02/08267

Priority 09/620,412 20.07.00 US; 09/841,132 23.04.01 US

Filing date 20 July 2001

Wipo publication date 5 February 2002

Acceptance publication date 24 January 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 39/118 (2006.01) Medicinal preparations containing antigens or antibodies - Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 14/295 (2006.01) Peptides having more than 20 amino acids

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12Q 1/06 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Quantitative determination

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

24 January 2008 Application Accepted

  Published as AU-B-2001280702

22 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001280703-Leucine-based motif and clostridial neurotoxins

2001280701